Skip to main content
XBI logo

State Street SPDR S&P Biotech ETF

XBINYSEARCAState StreetEquity

$145.88Today:−$4.67 (−3.10%)1Y +27.04%

As of Nov 16, 2026 close

Assets (AUM)
$10.19B
Expense ratio
0.35%
Dividend yield
0.37%
Holdings
166
52-week range
$113.06$169.89
Volume (live)
-
Avg. volume (3M)
9.68M

XBI ETF: State Street SPDR S&P Biotech ETF - Price, Holdings & Analysis

State Street SPDR S&P Biotech ETF Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Price & Trading Activity
Day's Range$145.51 - $151.28
52-Week High$169.89
52-Week Low$113.06
Open$150.30
Volume (last close)11.49M
Average Volume (3M)9.68M
Performance Metrics
1 Day Change−3.10%
1 Month Change+1.08%
6 Month Change+11.62%
YTD Change+20.05%
1 Year Change+27.04%
5 Year Change+18.67%
10 Year Change+119.43%
Dividend Information
Annual Dividend$0.54
Dividend Yield0.37%
Last Dividend Ex-DateJun 22, 2026
Dividend Growth YoY+1199.98%
Years Dividend Growth2
Fund Characteristics
Assets (AUM)$10.19B
Expense Ratio0.35%
Total Holdings166
Inception DateJan 30, 2006
Technical Indicators
50-Day MA$153.91
200-Day MA$143.08
RSI41.30
Stochastic %K2.50
Stochastic %D18.20

Source: Exchange price data and fund disclosures. Data as of Nov 16, 2026. Data sources and methodology

Compare XBI with other ETFs

XBI at a Glance

State Street SPDR S&P Biotech ETF (XBI) is an equity ETF from State Street, launched in January 2006. It manages $10.19B in assets and charges a 0.35% expense ratio, about $35 a year per $10,000 invested.

Based on holdings data updated Oct 4, 2026, it holds 166 positions. The largest are Moderna, Inc (MRNA, 2.81%), Twist Bioscience Corporation (TWST, 2.20%) and Natera, Inc. (NTRA, 1.82%). The top 10 holdings make up 17.6% of the fund. By sector it leans toward Healthcare (99.3%) and Financials (0.7%). 96.6% of assets are in the United States.

It pays distributions yielding 0.37% at the Nov 16, 2026 close, $0.54 per share over the trailing 12 months. As of the Nov 16, 2026 close, the share price is up 27.0% over one year, up 18.7% over five years and up 119.4% over ten years (price change, excluding distributions).

Frequently Asked Questions About State Street SPDR S&P Biotech ETF

What is the current price of XBI?

The latest XBI price is $145.88 (Nov 16, 2026 close). The 52-week range is $113.06–$169.89. The share price is up 27.0% over the past year (price change, excluding distributions).

What is the expense ratio for XBI?

XBI's annual expense ratio is 0.35%, about $35 a year for every $10,000 invested.

Does XBI pay dividends?

Yes, XBI pays a 0.37% dividend yield (trailing 12 months, at the Nov 16, 2026 close). The most recent ex-dividend date was June 22, 2026. View full dividend history in the Dividends section.

What are the top holdings of XBI?

In holdings data last updated Oct 4, 2026, XBI's largest holdings are Moderna, Inc (2.8%), Twist Bioscience Corporation (2.2%), Natera, Inc. (1.8%) (combined weight: 6.8%). The fund holds 166 total positions. View the complete portfolio breakdown in the Holdings section.

How concentrated is XBI's portfolio?

In holdings data updated Oct 4, 2026, the top 10 holdings make up 17.6% of XBI's assets across 166 positions. Its largest sector weight is Healthcare at 99.3%.

How large is XBI and when did it launch?

XBI manages $10.19B in assets. State Street launched the fund on January 30, 2006, about 20 years before the Nov 16, 2026 close.